Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Haemophilia ; 6(1): 47-9, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10632742

ABSTRACT

Venous thrombosis is a very rare occurrence in patients with haemophilia A. We report the case of a haemophiliac in whom initially a calf haematoma was suspected, but neither this nor deep venous thrombosis (DVT) could be confirmed on ultrasound scanning. Subsequently, a high segment venous thrombosis was diagnosed by venography in a portion of a duplicated superficial femoral vein. Treatment with factor VIII (FVIII) and low molecular weight heparin led to a successful resolution. The only other case we have been able to find in the literature occurred during FVIII replacement therapy, which was not the situation with our patient.


Subject(s)
Femoral Vein/abnormalities , Hemophilia A/complications , Venous Thrombosis/complications , Venous Thrombosis/etiology , Adult , Factor VIII/administration & dosage , Femoral Vein/pathology , Fibrinolytic Agents/administration & dosage , Hemophilia A/blood , Hemophilia A/therapy , Heparin, Low-Molecular-Weight/administration & dosage , Humans , Leg , Male , Pain , Risk Factors , Sepsis/drug therapy , Tinzaparin , Travel , Venous Thrombosis/blood
2.
Br J Clin Pharmacol ; 29(4): 403-12, 1990 Apr.
Article in English | MEDLINE | ID: mdl-2183866

ABSTRACT

1. Renal function was assessed in 10 healthy female volunteers during administration of placebo, paracetamol (acetaminophen) (4.0 g daily) and indomethacin (150 mg daily) for 3 days under conditions of controlled sodium and fluid intake. 2. Paracetamol and indomethacin had no significant effect on the glomerular filtration rate and effective renal plasma flow as measured by the renal clearances of inulin, creatinine and p-aminohippurate (PAH). 3. Compared with placebo, paracetamol reduced the mean urinary excretion of prostaglandin E2 by 43% on the second day and 58% on the third treatment day (P less than 0.01). With indomethacin the corresponding reductions were 73 and 80%. Paracetamol and indomethacin had much less effect on the excretion of prostaglandin 6-keto F1 alpha, and a significant decrease was observed only on the third day. 4. The decreased urinary excretion of prostaglandin E2, produced by paracetamol was associated with a reduction in sodium excretion of more than 50% (P less than 0.01) and delay in the onset of diuresis following an acute water load. 5. The renal effects of paracetamol and indomethacin appear to differ. Although indomethacin reduced prostaglandin excretion more than paracetamol it had a similar effect on sodium excretion and less initial antidiuretic action. Unlike paracetamol, indomethacin also reduced basal plasma renin activity. 6. Paracetamol reduced the total body clearance of PAH and increased its plasma half-life. This effect could be attributed to inhibition of the acetylation of PAH by paracetamol. 7. In normal use paracetamol does not appear to have the adverse renal effects associated with the non-steroidal anti-inflammatory analgesics and further studies are required to establish the clinical significance of these findings.


Subject(s)
Acetaminophen/pharmacology , Indomethacin/pharmacology , Kidney/drug effects , 6-Ketoprostaglandin F1 alpha/urine , Acetylglucosaminidase/urine , Adult , Creatinine/blood , Dinoprostone/urine , Female , Glomerular Filtration Rate/drug effects , Humans , Inulin/pharmacokinetics , Kidney Function Tests , Osmolar Concentration , Renal Circulation/drug effects , Renin/blood , Urodynamics/drug effects , beta 2-Microglobulin/urine , p-Aminohippuric Acid/blood
3.
Br J Haematol ; 86(1): 213-5, 1994 Jan.
Article in English | MEDLINE | ID: mdl-8011535

ABSTRACT

A 16-year-old youth with life-threatening virus-associated haemophagocytic syndrome (VAHS) responded remarkably to treatment with cyclosporin A during two periods of active disease, the second of which was due to noncompliance with treatment. Our clinical observations support the hypothesis that VAHS is cytokine driven as a result of an aberrant T-cell response to infection.


Subject(s)
Histiocytosis, Non-Langerhans-Cell/immunology , T-Lymphocytes/immunology , Virus Diseases/immunology , Adolescent , Cyclosporine/therapeutic use , Histiocytosis, Non-Langerhans-Cell/blood , Histiocytosis, Non-Langerhans-Cell/drug therapy , Humans , Male , Platelet Count
4.
Haemophilia ; 6(6): 709-12, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11122403

ABSTRACT

We present two cases in which the occurrence of acquired haemophilia is associated with the use of depot preparations of the thioxanthenes zuclopenthixol and flupenthixol. These drugs have not previously been implicated in the aetiology of acquired haemophilia.


Subject(s)
Antipsychotic Agents/adverse effects , Clopenthixol/adverse effects , Flupenthixol/adverse effects , Hemophilia A/etiology , Adult , Aged , Autoantibodies/immunology , Factor VIII/immunology , Female , Hemophilia A/immunology , Humans
SELECTION OF CITATIONS
SEARCH DETAIL